CDR-Life Announces First Milestone Achievement in Boehringer Ingelheim Autoimmune Partnership

AI Briefing

• – CDR-Life announces achievement of preclinical milestone under partnership with Boehringer Ingelheim for autoimmune disease treatment.
• – The milestone marks progress in developing next-generation antibody-based therapies for autoimmune diseases.
• – The candidate is a trispecific M-gager designed to treat cancer and autoimmune diseases.